2 results
19/Dec/2022
DOI: 10.31744/einstein_journal/2023AO0117
Highlights The incidence of acute myeloid leukemia was slightly higher in women. The most frequent aberrant marker in B-cell ALL was CD66c, followed by CD13 and CD33. Expression of CD34, HLA-DR, CD13, MPO, CD15, CD64, CD2 and CD7 was different in the non-APL and APL AML groups. Differences in expression of CD10, CD13, CD33, CD66c and CD34 were observed in different age groups with B-cell ALL. ABSTRACT Objective To characterize the immunophenotypic profile of acute leukemias in the population […]
Keywords: Acute myeloid leukemia; Flow cytometry; Immunophenotyping; Leukemia; Leukemia, myeloid, acute; Precursor B-cell lymphoblastic leukemia-lymphoma
01/Apr/2011
DOI: 10.1590/S1679-45082011AO1853
ABSTRACT Objective: To identify how the Brazilian hematology centers treated and diagnosed cases of acute myeloid leukemia in 2009. Methods: An epidemiological observational multicenter study of 11 listed Brazilian centers that treat acute myeloid leukemia and perform bone marrow transplantation. Data were collected from clinical charts of patients with acute myeloid leukemia treated at the said centers between 2005 and 2009. The availability for immunophenotyping and cytogenetic tests was assessed. Results: During 2009, a total of 345 new cases of […]
Keywords: Acute myeloid leukemia; Brazil; Cytogenetic analysis; Molecular diagnostic techniques; Therapeutics